It was shown, that the currently grade 3 tumor group (n = 381) was assembled of 12.9% of POLE ultramutated tumors, 20.7% of p53 abnormal tumors, 30.2% non-specific molecular profile (NSMP) tumors, and 36.2% of MMR deficient tumors. The gene discussed is TP53; the disease is neoplasm.